Family Medicine · Melbourne, FL
NPI
1467593780
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1223 Gateway Dr Ste 1a
Melbourne, FL, 32901
Phone (321) 312-3460
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
1,674 services
Medicare patients, 2024
346
Average age 74
Drug cost, 2024
$806K
8,894 prescriptions
Company payments, 2023
$22.43
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Myredsi Soto-Varela was code 99214 (office e&m - established), 763 times for 324 patients. In total Myredsi Soto-Varela billed 1,674 services in 33 codes, and Medicare paid $115K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 763 | 324 | $81.96 | $63K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 361 | 245 | $11.91 | $4,301 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 208 | 208 | $125.28 | $26K |
| 99213 Office E&M - Established | Office | 59 | 49 | $54.79 | $3,232 |
| G0008 Administration of influenza virus vaccine | Office | 27 | 25 | $31.66 | $855 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 22 | 22 | $159.88 | $3,517 |
| 90653 Vaccine Product | Office | 22 | 22 | $81.82 | $1,800 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 18 | 16 | $41.49 | $747 |
| 99204 Office E&M - New | Office | 14 | 14 | $87.12 | $1,220 |
By year: 2022 $87K for 1,044 services; 2023 $94K for 1,138 services; 2024 $115K for 1,674 services.
Medicare prescription drug claims, 2024
In 2024, the drug Myredsi Soto-Varela prescribed most often to Medicare patients was Atorvastatin Calcium, with 479 prescriptions and refills. In total Myredsi Soto-Varela wrote 8,894 Medicare prescriptions that cost $806K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 479 | 1,370 | 139 | $8,219 |
| Amlodipine Besylate Generic | 461 | 1,322 | 140 | $4,272 |
| Lisinopril Generic | 438 | 1,236 | 123 | $5,384 |
| Levothyroxine Sodium Generic | 407 | 1,168 | 119 | $7,283 |
| Losartan Potassium Generic | 276 | 779 | 76 | $4,651 |
| Rosuvastatin Calcium Generic | 255 | 738 | 89 | $5,634 |
| Hydrochlorothiazide Generic | 225 | 651 | 70 | $765 |
| Metformin Hcl Generic | 199 | 596 | 66 | $2,109 |
| Metoprolol Succinate Generic | 193 | 530 | 51 | $4,624 |
| Simvastatin Generic | 151 | 453 | 46 | $2,323 |
| Pantoprazole Sodium Generic | 150 | 416 | 56 | $2,846 |
| Gabapentin Generic | 147 | 363 | 58 | $2,388 |
| Omeprazole Generic | 139 | 393 | 55 | $2,050 |
| Alprazolam Generic | 133 | 203 | 42 | $947 |
| Sertraline Hcl Generic | 130 | 372 | 42 | $1,551 |
Brand drugs: 964 claims; generic drugs: 7,886 claims; opioid claims: 138.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Myredsi Soto-Varela $22.43 ($22.43 in general payments such as food, travel and fees) from 1 company. The largest payer was Hologic Sales and Service, LLC with $22.43.
| Company | Payments | Amount |
|---|---|---|
| Hologic Sales and Service, LLC HOLX | 1 | $22.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.